
Areas of Expertise
Conditions I Treat
- Pancreatic cancer
- Liver cancer and conditions
- Bile duct cancer (cholangiocarcinoma)
My Specialties
- Biomarker testing
Get to Know Me
I am a medical oncologist with expertise in the treatment of pancreatic, hepatobiliary, and other gastrointestinal cancers.
My research is focused on two areas: first, the discovery and implementation of biomarkers for the diagnosis of pancreatic cancer, and second, the development of more-effective treatments for pancreatic cancer. My research program is funded by the National Cancer Institute/National Institutes of Health, the Lustgarten Foundation, and the Thompson Family Foundation.
A gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
- Associate Attending Physician
Conditions I Treat
- Pancreatic cancer
- Liver cancer and conditions
- Bile duct cancer (cholangiocarcinoma)
- Gallbladder cancer
- Gastrointestinal cancers and conditions
My Specialties
- Biomarker testing
Education
- MSc, University of Pennsylvania
- MD, Johns Hopkins University
Residencies
- Internal Medicine - Hospital of the University of Pennsylvania
Fellowships
- Hematology/Oncology - Hospital of the University of Pennsylvania
Board Certifications
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Yu sees patients at one location.












Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Yu
- A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People with Advanced Pancreatic Cancer and BRCA Mutations
- Clinical Trials Co-Investigated by Dr. Yu
- A Phase 1 Study of AFNT-211 Cell Therapy in People With Solid Tumors
- A Phase 1/2 Study of TAC01-CLDN18.2 Cellular Therapy in People With Advanced Solid Tumors
- A Phase 1B Study of ELA026 in People with Secondary Hemophagocytic Lymphohistiocytosis
Read more

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Hewitt MR, Yu KH. Treatment update for metastatic pancreatic cancer. Community Oncology. 2006; 3(7) :428-30 .
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 128 reviews
- 4.8 Provider's Explanations Easy to Understand
- 4.9 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
I'm very happy with Dr. Yu.
That the doctors in MSK are extremely sensitive to my concerns. He has provided thee most excellent care to me. I'm very Thankful
Took excellent care of my wife.
Dr. Yu is a very caring doctor and I'm grateful for everything he has done for me.
I loved the optimism and the openness to new treatments. I felt cared for and heard.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kenneth H. Yu discloses the following relationships and financial interests:
-
Ipsen Pharma
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.